Baxter International | Nettoeinkommen

Aktienkurs
20.37
Täglich Wechseln
0.01 0.05%
Monatlich
3.88%
Jährlich
-40.97%
Q1 Prognose
20.91




Nettoeinkommen Veränderung Datum
Abbott USD 1.78B 132M 2025-12
AngioDynamics USD -4.41M 6.33M 2025-02
Artivion USD -2.29M 167K 2024-09
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Cooper Companies USD 84.6M 13.7M 2025-09
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Fresenius EUR 361M 17M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
J&J USD 5.12B 36M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Masimo USD -100.4M 151.7M 2025-09
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Quest Diagnostics USD 245M 0 2025-12
Smith & Nephew USD 293M 79M 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Terumo JPY 32.65B 2.4B 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12


Baxter International Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.